SO
SNDX icon

STRS Ohio’s Syndax Pharmaceuticals SNDX Stock Holding History

STRS Ohio’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,400
Closed -$104K – 2036
2024
Q3 		$104K Sell
5,400
-22,800
-81% -$471K ﹤0.01% 1699
2024
Q2 		$579K Buy
28,200
+2,900
+11% +$60.7K ﹤0.01% 1130
2024
Q1 		$602K Sell
25,300
-1,100
-4% -$24.5K ﹤0.01% 1135
2023
Q4 		$570K Sell
26,400
-600
-2% -$9.22K ﹤0.01% 1208
2023
Q3 		$392K Hold
27,000
– – ﹤0.01% 1368
2023
Q2 		$565K Buy
27,000
+2,100
+8% +$43.7K ﹤0.01% 1206
2023
Q1 		$525K Hold
24,900
– – ﹤0.01% 1292
2022
Q4 		$633K Hold
24,900
– – ﹤0.01% 1171
2022
Q3 		$598K Hold
24,900
– – ﹤0.01% 1236
2022
Q2 		$479K Buy
24,900
+1,400
+6% +$23.3K ﹤0.01% 1370
2022
Q1 		$408K Buy
+23,500
New +$396K ﹤0.01% 1519
2018
Q1 		– Sell
-1,500
Closed -$13K – 1908
2017
Q4 		$13K Hold
1,500
– – ﹤0.01% 1839
2017
Q3 		$17K Hold
1,500
– – ﹤0.01% 1875
2017
Q2 		$20K Hold
1,500
– – ﹤0.01% 1879
2017
Q1 		$20K Hold
1,500
– – ﹤0.01% 1832
2016
Q4 		$10K Hold
1,500
– – ﹤0.01% 1885
2016
Q3 		$22K Sell
1,500
-100
-6% -$1.31K ﹤0.01% 1835
2016
Q2 		$15K Buy
+1,600
New +$21.9K ﹤0.01% 1875

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

STRS Ohio's SNDX Position: Q4 2024 in Review

STRS Ohio sold out of Syndax Pharmaceuticals (SNDX) in Q4 2024, closing a stake of 5,400 shares — an estimated $104K sold.

STRS Ohio first reported a position in SNDX in Q2 2016 and held it in 18 quarters. The position peaked at $633K in Q4 2022. 215 funds tracked by Wall St. Rank hold SNDX as of Q4 2024.

  • STRS Ohio reported no remaining Syndax Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • STRS Ohio sold 5,400 Syndax Pharmaceuticals shares in Q4 2024, an estimated $104K.
  • STRS Ohio first reported a position in Syndax Pharmaceuticals in Q2 2016 and held it in 18 quarters.
  • STRS Ohio's Syndax Pharmaceuticals position peaked at $633K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2024.

Based on STRS Ohio's 13F filing for Q4 2024, filed 28 May 2025.